Oscar Health beats Q2 revenue estimates, raises 2026 outlook
OSCR•Outlook
- Oscar Health raises full-year 2026 earnings from operations outlook to $500 mln-$700 mln
- Company maintains full-year 2026 revenue guidance at $18.7 bln-$19.0 bln
- Oscar Health lowers full-year 2026 medical loss ratio forecast to 81.5%-82.5%
Overview
- US healthcare tech firm's Q2 revenue rose, beating analyst expectations
- Adjusted EBITDA for Q2 beat analyst expectations
- Company raised full-year 2026 outlook, citing disciplined pricing and favorable reserve development
Key details
| Metric | Beat/Miss | Actual | Consensus Estimate |
|---|---|---|---|
| Q2 Revenue | Beat | $4.88 bln | $4.75 bln (10 Analysts) |
| Q2 Net Income | $361.81 mln | ||
| Q2 Adjusted EBITDA | Beat | $415.35 mln | $188.42 mln (10 Analysts) |
